Revenue from operations rose 22 per cent to Rs 8,017 crore, led by India formulations, consumer wellness and international markets, while EBITDA margin contracted
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.